The Cannabis Industry Is Having A Price Compression Crisis
U.S. cannabis sales declined year over year for the first time on record
Key points:
- U.S. cannabis sales fell year over year for the first time, dropping from $32 billion in 2024 to $29.94 billion in 2025.
- But price compression, not weak demand, is the cause as consumers buy more and pay less.
- Analysts say cannabis regulators issue licenses seeking tax revenue, license fees and jobs rather than attempting to meet demand, leaving too many operators chasing smaller slices of the same market.
U.S. cannabis sales declined year over year for the first time on record, falling from $32 billion in 2024 to $29.94 billion in 2025, according to data compiled in the MJBiz Factbook.
The drop marks a turning point for an industry that has spent more than a decade posting steady and uninterrupted growth at the cash register even as valuations declined. But the cause isn’t shrinking demand or vanishing consumers. It’s collapsing prices, as cannabis consumers in some states bought more product than ever before even as sales revenue declined, analysts told MJBizDaily.
“The topline may look relatively stable, but that masks what is happening underneath it,” said Laurie Parfitt, CEO of Chicago-based firm LKP Impact Consulting.
“Price compression is doing more damage to revenue than declining consumer interest.”
Are US cannabis sales down?
The cannabis industry’s decade of expansion was built on the legalization wave. As states across the U.S. steadily converted from the illicit to the regulated market, consumers moved from illegal sources to licensed dispensaries.
“You would bring a couple of new states online,” economist Beau Whitney told MJBizDaily. “The influx of new consumers was driving revenue growth.”
To Read The Rest Of This Article On MJ Biz Daily, Click Here
